Search For "mabs"
Highest risk patients for severe COVID-19 least likely to get monoclonal a
Updated : 4 years, 3 months ago IST
Cambridge (Massachusetts) [US], February 6 (ANI): Ever since the COVID-19 pandemic hit the world, researchers have been giving every possible information to help in better treatment. According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the lea
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 4 years, 11 months ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
NIH launches clinical trial in US to test potential therapeutics for mild,
Updated : 5 years, 9 months ago IST
Washington D.C. [US], Aug 5 (Xinhua/ANI): The U.S. National Institutes of Health (NIH) said on Tuesday a Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics for COVID-19, including an investigational therapeutic based on synthetic monoclonal antibodies
Read More